Ublituximab reduces relapse rates and disability progression over 5 years in patients with relapsing multiple sclerosis.

Multiple sclerosis (MS) is a condition that disrupts the information pathways that connect your brain and your body. From time to time, the symptoms of MS can unexpectedly worsen. When symptoms ...

In stable MS patients, stopping Ocrevus does not seem to increase the risk of disease activity or disability progression for ...

Prenatal and early life sun exposure was associated with lower risk for relapse in children with pediatric-onset multiple sclerosis (MS), a new prospective cohort study showed. At least 30 minutes of ...

Even when doctors thought she was too young to have MS, Emily Marsh kept pushing for answers until an MRI led to her ...

Multiple sclerosis MS book and prescription and pen. A blood test might predict relapses in MS Neurofilament light chain levels spike in MS patients’ blood before a relapse However, the prediction ...

“Our data add and expand previous observations on silent progression in MS and are consistent with the view of the disease as a single continuum, in which RAW [relapse-associated worsening] and PIRA ...

MS is a devastating disease impacting 2.8 million people worldwide, including many young adults. Scientists warn of increased risk of developing MS from long-term air pollution exposure first appeared ...

Rituximab (Rituxan) provides consistently better relapse outcomes than natalizumab (Tysabri) in patients with multiple sclerosis (MS), new research suggests. Findings from a real-world "comparative ...

Overall, people with multiple sclerosis (MS) were not at increased risk of relapse after receiving booster doses of the COVID-19 vaccine, according to a large nationwide study in France. Among over ...

WASHINGTON (Reuters) - Breastfeeding may protect women with multiple sclerosis against relapses of their disease, possibly by delaying a return to normal monthly cycles, U.S. researchers reported on ...